REFRENCES :
[1] Tas S, Simonart T, Acta Clin Belg , Drug rash with eosinophilia and systemic symptoms (DRESS syndrome). 1999 ;54: 197 – 200.
[2] Callot V, Roujeau JC, Bagot M, et al, Arch Dermatol , Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. 1996 ;132: 1315 – 21.
[3] Jincy Thankachen, Vikram Agarwal, Am J Ther, Challenges in Diagnosis, Management, and Treatment of Allopurinol-Induced DRESS Syndrome: Case Report and Literature Review. 2015;22(3):e77-83.
[4] Y. T. Cho, C. W. Yang, and C. Y. Chu, International Journal of Molecular Sciences, Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system, 2017, vol. 18.
[5] Hoetzenecker W, Nägeli M, Mehra ET, Jensen AN, Saulite I, Schmid-Grendelmeier P, Guenova E, Cozzio A, Seminars in Immunopathology, ”Adverse cutaneous drug eruptions: current understanding”. 2016, 38 (1): 75–86.
[6] Braden GL, Warzynski MJ, Golightly M, Ballow M, Clin Immunol Immunopathol., Cell-mediated immunity in allopurinol-induced hypersensitivity. 1994;70:145–151.
[7] Cho YT, Yang CW, Chu CY ,International Journal of Molecular Sciences. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System. 2017, 18 (6): 1243.
[8] Bocquet H, Bagot M, Roujeau JC. Semin Cutan Med Surg, Drug‑induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms:DRESS). 1996;15:250‑7.
[9] Kardaun SH, Sidoroff A, Valeyrie Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Br J Dermatol , Variability in the clinical pattern of cutaneous side effects of drugs with systemic symptoms: Does a DRESS syndrome really exist? 2007;156:609 11
[10] Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. Br J Dermatol , The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. 2007;156:1083‑4.
[11] Arellano F, Sacristan JA. Ann Pharmacother ,Allopurinol hypersensitivity syndrome: a review. 1993;27:337–343.
[12] Cacoub P. Am J Med, The DRESS syndrome: a literature review. 2011;124:588–597.
[13] Jincy Thankachen, MSand Vikram Agarwal. American Journal of Therapeutics, Challenges in Diagnosis, Management, and Treatment of Allopurinol-Induced DRESS Syndrome: Case Report and literature Review. 2015, 22, e77–e83
[14] James J., Sammour Y. M., Virata A. R., Nordin T. A., Dumic I. American Journal of Case Reports, Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to furosemide: Case report and review of literature. 2018,19, 163-170.
[15] Bachot N, Roujeau JC. Am J Clin Dermatol .Differential diagnosis of severe cutaneous drug eruptions. 2003;4:561–572.
[16] Youssef Zemmez, Naoufal Hjira. Pan Afr Med J, Allopurinol-induced DRESS syndrome: Drug Reaction with Eosynophilia and Systemic Symptoms (DRESS).2018 Jun 12;30:120.
[17] Samer Hassan, Robert Wetz, Elie Zouein.Int J Gen Med, Allopurinol causing drug rash with eosinophilia and systemic symptoms syndrome: a challenging diagnosis. 2011; 4: 789–792.
[18] Mockenhaupt M. (2019). Drug reaction with eosinophilia and systemic symptoms (DRESS). Up to Date. Retrieved from https://www.uptodate.com/contents/drug-reaction-with-eosinophilia-and-systemic-s
[19] Sevinc C., Tasar T. T., Buyukkurt E. European Journal of Geriatric Gerontology. Approach to DRESS syndrome associated with allopurinol use in a geriatric patient. 2019, 1(3), 107-111.